NVAX Competitors & Alternatives
Compare Novavax Inc with similar stocks in the same industry
Biotechnology
NVAX
Main Stock$10.20
Tradestie Score
61
Market Cap
$1.54B
Revenue Growth
0.0%
Analyst Upside
+38.3%
Top Competitors
219 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
OCUL
Ocular Therapeutix, Inc.
|
$6.61
|
$1.92B | - | 65 | Compare |
|
CELC
Celcuity Inc. Common Stock
|
$67.05
|
$1.92B | - | 53 | Compare |
|
LQDA
Liquidia Corporation Common Stock
|
$51.40
|
$1.90B | 34.4 | 28 | Compare |
|
VERA
Vera Therapeutics, Inc. Class A Common Stock
|
$30.03
|
$1.84B | - | 47 | Compare |
|
IMCR
Immunocore Holdings plc American Depositary Shares
|
$32.38
|
$1.81B | - | 53 | Compare |
|
ABCL
AbCellera Biologics Inc. Common Shares
|
$12.46
|
$1.78B | - | 60 | Compare |
|
DYN
Dyne Therapeutics, Inc. Common Stock
|
$17.92
|
$1.78B | - | 36 | Compare |
|
TWST
Twist Bioscience Corporation Common Stock
|
$132.13
|
$1.77B | - | 57 | Compare |
|
VRDN
Viridian Therapeutics, Inc. Common Stock
|
$30.86
|
$1.74B | - | 39 | Compare |
|
CLDX
Celldex Therapeutics, Inc
|
$30.65
|
$1.68B | - | 63 | Compare |
More NVAX Analysis
Data updated: Nov 11, 2026 | Industry: Biotechnology (SIC 2836)
219 stocks in this industry